The stock price of Accelerate Diagnostics Inc (NASDAQ: AXDX) has dropped by -18.45 compared to previous close of 0.86. Despite this, the company has seen a fall of -33.96% in its stock price over the last five trading days. prnewswire.com reported 2025-03-21 that TUCSON, Ariz., March 21, 2025 /PRNewswire/ — Accelerate Diagnostics, Inc. (Nasdaq: AXDX), an innovator in rapid in vitro diagnostics for microbiology, today announced the submission of its Accelerate WAVE™ system and positive blood culture gram-negative test kit to the U.S. Food and Drug Administration (FDA) for 510(k) clearance.
Is It Worth Investing in Accelerate Diagnostics Inc (NASDAQ: AXDX) Right Now?
The stock has a 36-month beta value of 0.38. Opinions on the stock are mixed, with 1 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for AXDX is 15.35M, and at present, short sellers hold a 2.77% of that float. On March 31, 2025, the average trading volume of AXDX was 38.77K shares.
AXDX’s Market Performance
AXDX’s stock has seen a -33.96% decrease for the week, with a -35.19% drop in the past month and a -34.58% fall in the past quarter. The volatility ratio for the week is 17.70%, and the volatility levels for the past 30 days are at 10.78% for Accelerate Diagnostics Inc The simple moving average for the past 20 days is -33.40% for AXDX’s stock, with a -50.84% simple moving average for the past 200 days.
Analysts’ Opinion of AXDX
Many brokerage firms have already submitted their reports for AXDX stocks, with Craig Hallum repeating the rating for AXDX by listing it as a “Hold.” The predicted price for AXDX in the upcoming period, according to Craig Hallum is $5 based on the research report published on March 09, 2022 of the previous year 2022.
Craig Hallum gave a rating of “Buy” to AXDX, setting the target price at $20 in the report published on August 07th of the previous year.
AXDX Trading at -38.61% from the 50-Day Moving Average
After a stumble in the market that brought AXDX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -66.51% of loss for the given period.
Volatility was left at 10.78%, however, over the last 30 days, the volatility rate increased by 17.70%, as shares sank -35.19% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -38.05% lower at present.
During the last 5 trading sessions, AXDX fell by -33.96%, which changed the moving average for the period of 200-days by -44.44% in comparison to the 20-day moving average, which settled at $1.0511. In addition, Accelerate Diagnostics Inc saw -41.67% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at AXDX starting from Patience David, who sale 535 shares at the price of $1.09 back on Feb 26 ’25. After this action, Patience David now owns 51,384 shares of Accelerate Diagnostics Inc, valued at $583 using the latest closing price.
Phillips Jack, the Chief Executive Officer of Accelerate Diagnostics Inc, sale 485 shares at $1.35 during a trade that took place back on Feb 03 ’25, which means that Phillips Jack is holding 163,434 shares at $655 based on the most recent closing price.
Stock Fundamentals for AXDX
Current profitability levels for the company are sitting at:
- -3.02 for the present operating margin
- 0.23 for the gross margin
The net margin for Accelerate Diagnostics Inc stands at -4.28. The total capital return value is set at 13.35.
Based on Accelerate Diagnostics Inc (AXDX), the company’s capital structure generated 8.67 points at debt to capital in total, while cash flow to debt ratio is standing at -0.38. The debt to equity ratio resting at -1.13. The interest coverage ratio of the stock is -2.69.
Currently, EBITDA for the company is -33.57 million with net debt to EBITDA at -1.44. When we switch over and look at the enterprise to sales, we see a ratio of 5.63. The receivables turnover for the company is 5.74for trailing twelve months and the total asset turnover is 0.41. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.71.
Conclusion
To sum up, Accelerate Diagnostics Inc (AXDX) has seen a bad performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
